Pipeline

//Pipeline
Pipeline 2018-04-29T11:10:37+00:00

Diverse, promising pipeline of targeted cytotoxic drugs and immunotherapies for multiple oncology indications

Targeted Immunotherapeutic DSPs: early stage programs utilizing immune cell activating TNF-SF ligands, aimed at recruiting and stimulating immune activity in the tumor microenvironment (DSP105, DSP106, DSP107)

Pipeline Targeted Immunotherapeutic DSP
DSP105
DSP106
DSP107